MRI, Enhanced CT, and FDG PET/CT in Basal Cell Carcinoma of the Prostate

被引:2
作者
Dong, Aisheng [1 ]
Zuo, Changjing [1 ]
Lu, Jianping [2 ]
Wang, Yang [3 ]
机构
[1] Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Changhai Hosp, Dept Radiol, Shanghai 200433, Peoples R China
[3] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China
关键词
basal cell carcinoma; prostate cancer; prostate; MRI; CT; FDG; PET/CT;
D O I
10.1097/RLU.0000000000000280
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Primary basal cell carcinoma of the prostate is a very rare neoplasm with a good prognosis. A 55-year-old man presented with urinary frequency for 2 months. Serum prostate-specific antigen level was normal. T2-weighted MR images showed an inhomogeneously hyperintense tumor in the prostate. Enhanced CT showed heterogeneous enhancement of the tumor. FDG PET/CT showed strong FDG uptake of the tumor with SUVmax of 14.1. Prostate biopsy findings revealed basal cell carcinoma with high proliferation index.
引用
收藏
页码:721 / 724
页数:4
相关论文
共 50 条
[21]   Squamous Cell Carcinoma of the Right Kidney on FDG PET-CT [J].
Ho, Linh ;
Modarresifar, Homayoun ;
Henderson, Robert .
CLINICAL NUCLEAR MEDICINE, 2008, 33 (12) :892-893
[22]   FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation [J].
Zhu, Hongjing ;
Zhao, Shuai ;
Zuo, Changjing ;
Ren, Fangyuan .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (03) :645-651
[23]   Improving liver lesion characterisation using retrospective fusion of FDG PET/CT and MRI [J].
Parsai, Arman ;
Miquel, Marc E. ;
Jan, Hikmat ;
Kastler, Adrian ;
Szyszko, Teresa ;
Zerizer, Imene .
CLINICAL IMAGING, 2019, 55 :23-28
[24]   MRI and FDG PET/CT findings for small cell neuroendocrine carcinoma of the ovary: a case report and literature review [J].
Matsutani, Hiroki ;
Nakai, Go ;
Yamada, Takashi ;
Kurisu, Yoshitaka ;
Yamamoto, Kazuhiro ;
Ohmichi, Masahide ;
Osuga, Keigo .
BMC WOMENS HEALTH, 2025, 25 (01)
[25]   Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis [J].
Burian, Egon ;
Palla, Benjamin ;
Callahan, Nicholas ;
Pyka, Thomas ;
Wolff, Constantin ;
von Schacky, Claudio E. ;
Schmid, Annabelle ;
Froelich, Matthias F. ;
Rubenthaler, Johannes ;
Makowski, Marcus R. ;
Gassert, Felix G. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (11) :3870-3877
[26]   Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis [J].
Egon Burian ;
Benjamin Palla ;
Nicholas Callahan ;
Thomas Pyka ;
Constantin Wolff ;
Claudio E. von Schacky ;
Annabelle Schmid ;
Matthias F. Froelich ;
Johannes Rübenthaler ;
Marcus R. Makowski ;
Felix G. Gassert .
European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 :3870-3877
[27]   FDG PET/CT Demonstration of Pancreatic Metastasis From Prostate Cancer [J].
Desai, Bhushan ;
Elatre, Wafaa ;
Quinn, David I. ;
Jadvar, Hossein .
CLINICAL NUCLEAR MEDICINE, 2011, 36 (10) :961-962
[28]   FDG-PET/CT in Evaluation and Prognostication of Primary Prostate Lymphoma [J].
Hodgson, Richard ;
Huang, Yi-Tung ;
Steinke, Karin ;
Kumar, Aravind S. Ravi .
CLINICAL NUCLEAR MEDICINE, 2010, 35 (06) :418-420
[29]   Imaging biomarkers in prostate cancer: role of PET/CT and MRI [J].
Picchio, M. ;
Mapelli, P. ;
Panebianco, V. ;
Castellucci, P. ;
Incerti, E. ;
Briganti, A. ;
Gandaglia, G. ;
Kirienko, M. ;
Barchetti, F. ;
Nanni, C. ;
Montorsi, F. ;
Gianolli, L. ;
Fanti, S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (04) :644-655
[30]   Imaging biomarkers in prostate cancer: role of PET/CT and MRI [J].
M. Picchio ;
P. Mapelli ;
V. Panebianco ;
P. Castellucci ;
E. Incerti ;
A. Briganti ;
G. Gandaglia ;
M. Kirienko ;
F. Barchetti ;
C. Nanni ;
F. Montorsi ;
L. Gianolli ;
S. Fanti .
European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 :644-655